FDA panel narrowly sides against experimental ALS drug 0 31.03.2022 00:21 The Independent Federal health advisers have narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig’s disease Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа